Regenerative Medicine Companies

*Disclaimer: List of key companies in no particular orderLatest regenerative medicine Companies Update

• 
  Oct 2023: Subject to a few closing adjustments, the previously announced $4.25 billion cash acquisition of Baxter International's BioPharma Solutions (BPS) business by global private equity investors Advent International (Advent) and Warburg Pincus has been completed. As a result of the transaction, the company will function as a stand-alone contract development and manufacturing organization and go by the name Simtra BioPharma Solutions (Simtra). According to a press release from the company, Simtra will keep providing the same services and tools offered under the BPS brand to guarantee the continuous supply of essential pharmaceutical items worldwide.

• 
  Jun 2023: AbbVie Inc., a US-based pharmaceutical company, has given $25 million to global pharmaceutical giant Lupin to start Phase 1 clinical trials to create a potential blood cancer treatment. This funding comes after Lupin reported the completion of a significant milestone in its innovative MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor development. Lupin Limited's innovative MALT1 inhibitor program aims to produce a drug that can suppress the action of MALT1, a protein linked to forms of lymphomas.   The initiative aims to create a novel medicine that can prevent cancer cells from growing and surviving by blocking MALT1. Through pre-clinical and clinical trials, this program—a collaboration between Lupin Limited and AbbVie Inc.—will investigate the efficacy and safety of the MALT1 inhibitor. The objective is to create a novel hematological cancer therapeutic alternative.

• Zimmer Biomet Holdings Inc. (US)


• AbbVie Inc. (US)


• Cryolife, Inc. (US)


• Stryker (US)


• Medtronic Plc (Ireland)


• Baxter International Inc. (US)


• Organogenesis Inc. (US)


• Ocata Therapeutics Inc. (US)


• Integra Lifesciences Holdings Corporation (US)


• Vericel Corporation (US)


• Reliance Life Sciences (India)